Friday, November 22, 2024
HomeTagsRADICAVA

RADICAVA

Mitsubishi Tanabe Pharma America Announces FDA Acceptance of New Drug Application (NDA) for Oral Edaravone Formulation for the Treatment of ALS

Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for an investigational...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics